06 January 2004
Aneurysm: prevention and nonsurgical repair
John T.A. ElyMed Sci Monit 2004; 10(1): HY1-4 :: ID: 11560
Abstract
The approximately 4000 ‘normal’ mammals that synthesize ascorbic acid produce on average circa 50 mg/kg per day routinely. Although humans have the same needs as normal mammals, they do not produce ascorbic acid at all and, on average, ingest only circa 1 mg/kg per day. The normal mammals’ much larger production enables them to continually renew structural proteins, including both collagen, a flexible but inelastic tissue, and elastin, the elastic connective tissue. As a result, many normal mammals maintain a ‘youthful’ appearance with little gross anatomical change from age of maturity (i.e, first estrus) to more than 20 times age of maturity. In stark contrast, the extremely small ascorbic acid intake of humans does not enable them to maintain a youthful flexibility and elasticity beyond possibly 6 times age of maturity (most have died before 8 times). This loss of youthful qualities in structural proteins results in susceptibility for many forms of deterioration in both appearance and properties of vascular and other structural tissues. One such deterioration is aortic aneurysm, a common cause of morbidity and mortality. We hypothesize herein that improved dietary intake of essential nutrients needed to enhance the renewal of all structural proteins can: (1) prevent this deterioration completely; and (2) cure even large aortic aneurysms without surgery.
Keywords: Aortic Aneurysm - diet therapy, Aortic Aneurysm - metabolism, Aortic Aneurysm - prevention & control, Ascorbic Acid - administration & dosage, Collagen - metabolism, Elastic Tissue - metabolism, Elastin - metabolism, Longevity, Models, Cardiovascular, Aortic Aneurysm - prevention & control, Ascorbic Acid - administration & dosage, Collagen - metabolism, Elastic Tissue - metabolism, Elastin - metabolism, Longevity, Models, Cardiovascular
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952